KIM MIKER: Open Payments
NPI 1760056766 · SKOKOMISH NATION, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 28 payments from 12 companies in 2025. Trend: 2023 $125 · 2024 $0 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $162 |
| Axsome Therapeutics, Inc. | 3 | $155 |
| Neurocrine BioSciences, Inc. | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $66 |
| Alkermes, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Indivior Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $28 |
Products named: AIRSUPRA, Auvelity, INGREZZA, REXULTI, ARISTADA, VRAYLAR, CAPLYTA, AUSTEDO XR.
Industry payments across WA — which companies pay providers there.
